|
US5952294A
(en)
|
1996-07-31 |
1999-09-14 |
University Of Pittsburgh Of The Commonwealth System Of Higher Education |
Peptidyl prodrugs and methods of making and using the same
|
|
AU9797998A
(en)
|
1997-10-10 |
1999-05-03 |
Trustees Of The University Of Pennsylvania, The |
Compositions and methods for inhibiting arginase activity
|
|
EP1399467A4
(en)
|
2001-05-09 |
2004-09-15 |
Newbiotics Inc |
PRODRUGS ACTIVATED BY PEPTIDDEFORMYLASE
|
|
TWI380996B
(zh)
|
2004-09-17 |
2013-01-01 |
Hoffmann La Roche |
抗ｏｘ４０ｌ抗體
|
|
PT2343320T
(pt)
|
2005-03-25 |
2018-01-23 |
Gitr Inc |
Anticorpos anti-gitr e as suas utilizações
|
|
PT1907424E
(pt)
|
2005-07-01 |
2015-10-09 |
Squibb & Sons Llc |
Anticorpos monoclonais humanos para o ligando 1 de morte programada (pd-l1)
|
|
EP1987839A1
(en)
|
2007-04-30 |
2008-11-05 |
I.N.S.E.R.M. Institut National de la Sante et de la Recherche Medicale |
Cytotoxic anti-LAG-3 monoclonal antibody and its use in the treatment or prevention of organ transplant rejection and autoimmune disease
|
|
ES2371514T3
(es)
|
2007-07-03 |
2012-01-04 |
Actelion Pharmaceuticals Ltd. |
Compuestos de 3-aza-biciclo[3.3.0]octano.
|
|
US8591886B2
(en)
|
2007-07-12 |
2013-11-26 |
Gitr, Inc. |
Combination therapies employing GITR binding molecules
|
|
EP2044949A1
(en)
|
2007-10-05 |
2009-04-08 |
Immutep |
Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response
|
|
EP2249853A4
(en)
|
2008-01-30 |
2012-12-26 |
Univ Indiana Res & Tech Corp |
ESTER BASED PEPTIDE PRODRUGS
|
|
EP2730579A1
(en)
|
2008-06-17 |
2014-05-14 |
Millennium Pharmaceuticals, Inc. |
Boronate ester compounds and pharmaceutical compositions thereof
|
|
AR072999A1
(es)
|
2008-08-11 |
2010-10-06 |
Medarex Inc |
Anticuerpos humanos que se unen al gen 3 de activacion linfocitaria (lag-3) y los usos de estos
|
|
KR20110091784A
(ko)
|
2008-11-26 |
2011-08-12 |
아보트 러보러터리즈 |
칼슘 채널 차단제로서의 치환된 옥타하이드로사이클로펜타［ｃ］피롤4아민
|
|
EP3255060A1
(en)
|
2008-12-09 |
2017-12-13 |
F. Hoffmann-La Roche AG |
Anti-pd-l1 antibodies and their use to enhance t-cell function
|
|
RU2488390C2
(ru)
|
2008-12-29 |
2013-07-27 |
Тартуский Университет |
Ингибиторы аргиназы для лечения депрессии
|
|
LT2389352T
(lt)
|
2009-01-26 |
2019-06-10 |
The Trustees Of The University Of Pennsylvania |
Arginazės inhibitoriai ir naudojimo būdai
|
|
KR101790802B1
(ko)
|
2009-09-03 |
2017-10-27 |
머크 샤프 앤드 돔 코포레이션 |
항-ｇｉｔｒ 항체
|
|
ES2722300T3
(es)
|
2009-12-10 |
2019-08-09 |
Hoffmann La Roche |
Anticuerpos que se unen preferentemente al dominio extracelular 4 de CSF1R y su uso
|
|
JP5989547B2
(ja)
|
2010-03-05 |
2016-09-07 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
ヒトｃｓｆ−１ｒに対する抗体及びその使用
|
|
US9169323B2
(en)
|
2010-03-05 |
2015-10-27 |
Hoffmann-La Roche Inc. |
Antibodies against human CSF-1R
|
|
SG10201503168VA
(en)
|
2010-04-22 |
2015-06-29 |
Mars Inc |
Inhibitors of arginase and their therapeutic applications
|
|
HRP20190047T1
(hr)
|
2010-05-04 |
2019-02-22 |
Five Prime Therapeutics, Inc. |
Protutijela koja se vežu na csf1r
|
|
MX337040B
(es)
|
2010-09-09 |
2016-02-09 |
Pfizer |
Moleculas de union a 4-1bb.
|
|
HRP20160305T1
(hr)
*
|
2010-10-26 |
2016-07-01 |
Mars, Incorporated |
Borati kao inhibitori arginaze
|
|
CA2824599C
(en)
|
2010-12-31 |
2020-03-10 |
Astrazeneca Uk Limited |
Arginase inhibitors and methods of use thereof
|
|
JP6072771B2
(ja)
|
2011-04-20 |
2017-02-01 |
メディミューン，エルエルシー |
Ｂ７−ｈ１およびｐｄ−１に結合する抗体およびその他の分子
|
|
WO2013059437A1
(en)
|
2011-10-19 |
2013-04-25 |
Mars, Incorporated |
Inhibitors of arginase and their therapeutic applications
|
|
KR101764096B1
(ko)
|
2011-11-28 |
2017-08-02 |
메르크 파텐트 게엠베하 |
항-ｐｄ-ｌ1 항체 및 그의 용도
|
|
RU2658603C2
(ru)
|
2011-12-15 |
2018-06-21 |
Ф.Хоффманн-Ля Рош Аг |
Антитела против человеческого csf-1r и их применения
|
|
KR20140127855A
(ko)
|
2012-02-06 |
2014-11-04 |
제넨테크, 인크. |
Csf1r 억제제를 사용하는 조성물 및 방법
|
|
AR090263A1
(es)
|
2012-03-08 |
2014-10-29 |
Hoffmann La Roche |
Terapia combinada de anticuerpos contra el csf-1r humano y las utilizaciones de la misma
|
|
CN104540836B
(zh)
|
2012-04-18 |
2016-11-09 |
马尔斯公司 |
作为精氨酸酶抑制剂的环约束类似物
|
|
RU2670743C9
(ru)
|
2012-05-11 |
2018-12-19 |
Файв Прайм Терапьютикс, Инк. |
Способы лечения состояний антителами, которые связывают рецептор колониестимулирующего фактора 1 (csf1r)
|
|
UY34887A
(es)
|
2012-07-02 |
2013-12-31 |
Bristol Myers Squibb Company Una Corporacion Del Estado De Delaware |
Optimización de anticuerpos que se fijan al gen de activación de linfocitos 3 (lag-3) y sus usos
|
|
WO2014007831A1
(en)
|
2012-07-06 |
2014-01-09 |
Anacor Pharmaceuticals, Inc. |
Boron-containing small molecules
|
|
CN107759690A
(zh)
|
2012-08-31 |
2018-03-06 |
戊瑞治疗有限公司 |
用结合群落刺激因子1受体(csf1r)的抗体治疗病状的方法
|
|
AU2014278172B2
(en)
|
2013-06-12 |
2018-08-09 |
Mycovia Pharmaceuticals, Inc. |
Metalloenzyme inhibitor compounds
|
|
WO2015160664A1
(en)
|
2014-04-15 |
2015-10-22 |
Dow Agrosciences Llc |
Metalloenzyme inhibitor compounds as fungicides
|
|
CL2014002403A1
(es)
|
2014-09-11 |
2015-01-09 |
Univ Pontificia Catolica Chile |
Metodo para la preparacion enantioselectiva y purificacion del acido 2(s)-amino-6-boronohexanoico (abh) a partir de la disolucion de bpb-ni-gly en tetrahidrofurano, neutralizacion y posterior extraccion con diclorometano, disolucion en un alcohol c1-c5, enfriamiento para lograr la precipitacion de bpb, obtencion de abh y su posterior purificacion.
|
|
JO3579B1
(ar)
|
2014-09-26 |
2020-07-05 |
Luc Therapeutics Inc |
مُعدِلات تفاغرية سالبة لمستقبل nr2b من المركب n-ألكيل أريل-5-أوكسي أريل-ثامن هيدرو-خماسي الحلقة [c] بيرول
|
|
WO2016100555A1
(en)
*
|
2014-12-18 |
2016-06-23 |
Inception 4, Inc. |
Boronic acid derivatives and uses thereof
|
|
PL410665A1
(pl)
|
2014-12-29 |
2016-07-04 |
Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością |
Inhibitory arginazy oraz ich zastosowania terapeutyczne
|
|
US10143699B2
(en)
*
|
2015-06-23 |
2018-12-04 |
Calithera Biosciences, Inc. |
Compositions and methods for inhibiting arginase activity
|
|
SG11201802961PA
(en)
|
2015-10-30 |
2018-05-30 |
Calithera Biosciences Inc |
Compositions and methods for inhibiting arginase activity
|
|
PL417066A1
(pl)
|
2016-05-04 |
2017-11-06 |
Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością |
Inhibitory arginazy oraz ich zastosowania terapeutyczne
|
|
JP2020502259A
(ja)
|
2016-11-08 |
2020-01-23 |
カリセラ バイオサイエンシズ，インコーポレイテッド |
アルギナーゼ阻害剤併用療法
|
|
US10676431B2
(en)
|
2018-03-05 |
2020-06-09 |
Bristol-Myers Squibb Company |
Phenylpyrrolidinone formyl peptide 2 receptor agonists
|
|
WO2019245890A1
(en)
|
2018-06-20 |
2019-12-26 |
Merck Sharp & Dohme Corp. |
Arginase inhibitors and methods of use
|